Philcare Pharma
- Company typePrivate
- Founded2010
- HeadquartersManila, Philippines
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
Philcare Pharma firmographics
Firmographics- Name
- Philcare Pharma
- Legal name
- Philcare Pharma Inc.
- Website
- https://philcarepharma.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Philcare Pharma industry classification
Industry- Product category
- Specialty Pharmaceuticals
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Generic Hospital & Institutional Products (HLAIABAL)
- akta.pro secondary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
Keywords
Where Philcare Pharma is headquartered
LocationHeadquarters
- HQ city
- Manila
- HQ country
- Philippines
- HQ region
- Asia
Offices1 record
Markets served
Philcare Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Pharmaceutical Products Sales: Sale of branded generic pharmaceutical products in IV Anesthesia and Critical Care segments, including anesthesia/pain management, infective care, and critical care solutions. Products sold to hospitals and healthcare professionals nationwide.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels2 records
Philcare Pharma product offering
Product offeringCore offering
Philcare Pharma Inc. distributes branded generic pharmaceutical products in IV Anesthesia, Pain Management, Infective Care, and Critical Care therapeutic segments, along with one medical device (TroClose 1200 port closure system). Products are manufactured by globally certified partners (Baxter Pharma India, SRS Lifesciences Singapore, Vioser SA Greece) and sold to DOH and privately owned hospitals and healthcare professionals across the Philippines via a nationwide Medical Sales Representative network.
Product overview
Philcare Pharma Inc. is a 100% Filipino-owned pharmaceutical company specializing in IV anesthesia, pain management, anti-infective, and critical care therapeutic segments. The company offers a portfolio of 12 branded generic pharmaceutical products alongside one medical device (TroClose 1200). The product lineup is organized into three main therapeutic categories: (1) Anesthesia/Pain Management solutions including BUPICAN, BUPICAN HVY, TAMIN, and NAVOM; (2) Anti-infective/Antibiotic products including COLISAN-2, IMATIG, SANTRON, and IMTEC; and (3) Critical Care injectables including ADESAN, SANTON, NITROSAN, ESMOLIFE, and SANDINE. The company distributes through medical sales representatives nationwide and products are available in leading DOH and privately owned hospitals.
Differentiator
Problem solved
Functional benefit
Products and services
- BUPICAN (bupivacaine iso) Bupivacaine isotonic formulation used as a local anesthetic for surgical procedures, targeted at hospital anesthesia departments.
- BUPICAN HVY (bupivacaine w/dextrose) Heavy bupivacaine with dextrose for spinal anesthesia in surgical settings, targeted at hospital anesthesia departments.
- TAMIN 50/100 (IV Paracetamol 500mg/1g) Intravenous paracetamol formulation available in 500mg and 1g doses for pain management and fever reduction in hospital settings.
- NAVOM (Diclofenac sodium) NSAID injection for acute pain and inflammation management in hospital settings.
- COLISAN-2 (Colistimethate Sodium 2,000,000 IU) Colistimethate sodium injection for treating Gram-negative bacterial infections, particularly in critical care settings.
- IMATIG (Tigecycline 50ml) Tigecycline injection for treating complicated skin and intra-abdominal infections caused by resistant bacteria.
- SANTRON (Aztreonam 1g Powder for Injection) Monobactam antibiotic powder for injection used to treat gram-negative bacterial infections in hospitalized patients.
- IMTEC (Teicoplanin 400mg) Glycopeptide antibiotic injection for treating serious Gram-positive bacterial infections including MRSA.
- ADESAN (Adenosine 3mg/ml) Antiarrhythmic agent for treating supraventricular tachycardias and for cardiac diagnostic procedures.
- SANTON (Phenytoin Sodium 50mg/ml) Anticonvulsant medication for treating seizures in critical care and surgical settings.
- NITROSAN (Nitroglycerin 1mg/ml) Vasodilator for treating acute angina, hypertensive emergencies, and for controlled hypotension during surgery.
- ESMOLIFE (Esmolol HCl 10mg/ml) Short-acting beta-blocker for rapid rate control in cardiac arrhythmias and perioperative tachycardia.
- SANDINE (Norepinephrine Bitartrate 4mg/4ml) Vasopressor for treating acute hypotension and shock states in critical care settings.
- TroClose 1200 Novel integrated port closure system for closing surgical port sites after minimally invasive procedures, designed to be simple, secure, and safe.
Companies that use Philcare Pharma
Customer profileNamed customers4 records
Segments2 records
Ideal customer profiles2 records
Philcare Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Philcare Pharma partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core, minor and supporting.
- SRS Lifesciences Ltd. (Singapore)coreManufacturing partner specializing in injectable pharmaceuticals. Facility holds UK MHRA and FDA Philippines certifications. Partnership established in 2013 for distribution of branded generic products.
- Baxter Pharma India Pvt. Ltd. (Claris)coreManufacturing partner supplying high-quality pharmaceutical products. Facility holds US FDA, UK MHRA, and FDA Philippines certifications. Partnership established in 2010, making it the longest-standing partnership for Philcare Pharma.
- Vioser SA (Greece)minorStrategic partnership for expansion into small volume sterile IV fluids. Facility holds EU GMP and FDA Philippines certifications.
- CeDRES, Inc. ManilasupportingQuality assurance partner that conducts regular bio-assay testing and evaluation for all Philcare products, ensuring product efficacy and safety standards.
Scale indicators7 records
Recent moves5 records
Expansion highlights4 records
Philcare Pharma competitors and assessment
Company assessmentDirect peers
- Fresenius Kabi Philippines: Global leader in IV generics, anesthesia, and critical care injectables with strong presence in the Philippines hospital channel. Overlaps directly with Philcare's IV anesthesia and critical care portfolio.
- B. Braun Philippines: Sells IV fluids, anesthesia, and critical care medical products to Philippine hospitals. Highly comparable therapeutic focus and hospital-channel GTM.
- Unilab (United Laboratories Inc.): Largest Filipino pharmaceutical company distributing branded generics and innovative drugs through a nationwide hospital and retail network. Direct comparable in Philippine pharma distribution scale and GTM motion.
- Claris Lifesciences (Baxter/Claris Injectables): Philcare's longest-standing manufacturing partner (Baxter Pharma India / Claris) for sterile injectables. Comparable in product category and regulatory certifications (US FDA, UK MHRA).
Emerging players
- Gordian Surgical: Developer/manufacturer of the TroClose 1200 port closure system that Philcare distributes in the Philippines. Direct source-partner for Philcare's medical device line.
- Amsel Medical: Developer of port closure and surgical site management devices — partial overlap with Philcare's TroClose 1200 product category.
Broad incumbents
- Zydus Healthcare Philippines: Indian-origin generic pharmaceutical company with a Philippines distribution presence in branded generics and hospital injectables. Comparable in cross-border generic injectable distribution model.
- Pfizer Philippines: Multinational pharma incumbent with a broad hospital-channel portfolio that competes head-on in anesthesia, anti-infectives, and critical care categories in the Philippines.
Regional players
- Getz Pharma Philippines: Pakistan-based branded generic pharmaceutical company with Philippines operations focused on hospital-channel injectables and specialty therapeutics — comparable therapeutic focus and emerging-market GTM.
- Lupin Philippines: Indian-headquartered generic injectables manufacturer with select distribution into Southeast Asian hospital channels. Comparable generic injectable manufacturing and Asian distribution model.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Philcare Pharma social profiles
Digital presencePhilcare Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Philcare Pharma leadership team
Management profileNumber of profiles
Philcare Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Philcare Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Philcare Pharma
What does Philcare Pharma do?
Philcare Pharma Inc. distributes branded generic pharmaceutical products in IV Anesthesia, Pain Management, Infective Care, and Critical Care therapeutic segments, along with one medical device (TroClose 1200 port closure system). Products are manufactured by globally certified partners (Baxter Pharma India, SRS Lifesciences Singapore, Vioser SA Greece) and sold to DOH and privately owned hospitals and healthcare professionals across the Philippines via a nationwide Medical Sales Representative network.
Is Philcare Pharma a public or private company?
Philcare Pharma is a private company. It is classified as family owned and is currently operating.
When was Philcare Pharma founded?
Philcare Pharma was founded in 2010. It employs 101 to 250 people.
Where is Philcare Pharma based?
Philcare Pharma is headquartered in Manila, Philippines, in the Asia region.
How does Philcare Pharma make money?
One revenue line is on record: pharmaceutical Products Sales.
Who are Philcare Pharma's main competitors?
Direct peers on record are Fresenius Kabi Philippines, B. Braun Philippines, Unilab (United Laboratories Inc.) and Claris Lifesciences (Baxter/Claris Injectables). Emerging players are Gordian Surgical and Amsel Medical. Broad incumbents are Zydus Healthcare Philippines and Pfizer Philippines. Regional players are Getz Pharma Philippines and Lupin Philippines.
Does Philcare Pharma have an API?
No public API is recorded for Philcare Pharma.
What industry is Philcare Pharma in?
Philcare Pharma's product category is Specialty Pharmaceuticals. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products, with a secondary code of HLAIAJAB, Specialty Pharmaceutical Distributors. Its NAICS code is 424210 and its SIC code is 5122.